BlackRock Fund Advisors’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

BlackRock Fund Advisors’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,132	Closed	–	–	4300
2016 Q3	$0	Buy	2,132 +201	+10%	+$46	﹤0.01%	4291
2016 Q2	$1K	Buy	1,931 +128	+7%	+$36	﹤0.01%	4325
2016 Q1	$0	Buy	1,803 +308	+21%	+$86	﹤0.01%	4343
2015 Q4	$3K	Buy	+1,495	New	+$2.63K	﹤0.01%	4268
2014 Q2	–	Sell	-84,249	Closed	-$538K	–	3923
2014 Q1	$538K	Buy	+84,249	New	+$760K	﹤0.01%	3245

Other funds holding TLOG

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BWA

Burt Wealth Advisors North Bethesda, Maryland $407M AUM 11.98% 1-Year Est. Return

BlackRock Fund Advisors's TLOG Position: Q4 2016 in Review

BlackRock Fund Advisors sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q4 2016, closing a stake of 2,132 shares.

BlackRock Fund Advisors first reported a position in TLOG in Q1 2014 and held it in 5 quarters. The position peaked at $538K in Q1 2014. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.

BlackRock Fund Advisors reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q4 2016 after selling out during the quarter.
BlackRock Fund Advisors sold 2,132 TetraLogic Pharmaceuticals Corporation shares in Q4 2016.
BlackRock Fund Advisors first reported a position in TetraLogic Pharmaceuticals Corporation in Q1 2014 and held it in 5 quarters.
BlackRock Fund Advisors's TetraLogic Pharmaceuticals Corporation position peaked at $538K in Q1 2014.
3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.